FENNEC PHARMACEUTICALS INC. - Common stock, no par value (the "Shares") (FENC)
CUSIP: 31447P100
Q3 2018 13F Holders as of 30 Sep 2018
- Type / Class
- Equity / Common stock, no par value (the "Shares")
- Shares outstanding
- 34,145,841
- Total 13F shares
- 9,435,050
- Share change
- +41,313
- Total reported value
- $77,373,042
- Price per share
- $8.20
- Number of holders
- 45
- Value change
- -$276,921
- Number of buys
- 20
- Number of sells
- 12
Quarterly Holders Quick Answers
What is CUSIP 31447P100?
CUSIP 31447P100 identifies FENC - FENNEC PHARMACEUTICALS INC. - Common stock, no par value (the "Shares") in SEC institutional holdings data.
Need full ownership history?
Open the full security ownership history page.
Related Filing Research
- Latest 13F filings for newly reported positions.
- Latest Schedule 13D/13G reports for ownership changes outside 13F cadence.
- Latest 10-Q/10-K reports for financial context tied to this issuer.
- Recent insider transactions for executive and insider activity.
- SEC investors directory and top value investors for manager drilldown.
- Back to full security ownership history.
Explore More Reporting Periods
Jump to adjacent filing periods for faster comparison and easier crawl discovery.
Recent filing periods for CUSIP 31447P100:
Top shareholders of FENC - FENNEC PHARMACEUTICALS INC. - Common stock, no par value (the "Shares") (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| Southpoint Capital Advisors LP |
13F
|
Company |
12%
|
3,997,214
|
$41,731,000 | — | 30 Jun 2018 | |
| Avoro Capital Advisors LLC |
13F
|
Company |
3%
|
1,022,666
|
$10,700,000 | — | 30 Jun 2018 | |
| Opaleye Management Inc. |
13F
|
Company |
2.8%
|
945,000
|
$9,865,000 | — | 30 Jun 2018 | |
| 683 Capital Management, LLC |
13F
|
Company |
2.5%
|
867,185
|
$9,053,000 | — | 30 Jun 2018 | |
| EVENTIDE ASSET MANAGEMENT, LLC |
13F
|
Company |
2.2%
|
741,175
|
$7,738,000 | — | 30 Jun 2018 | |
| BlackRock Finance, Inc. |
13F
|
Company |
1.6%
|
555,044
|
$5,795,000 | — | 30 Jun 2018 | |
| PUTNAM INVESTMENTS LLC |
13F
|
Company |
0.77%
|
263,433
|
$2,750,000 | — | 30 Jun 2018 | |
| ACUTA CAPITAL PARTNERS, LLC |
13F
|
Company |
0.73%
|
250,000
|
$2,610,000 | — | 30 Jun 2018 | |
| STATE STREET CORP |
13F
|
Company |
0.43%
|
148,325
|
$1,549,000 | — | 30 Jun 2018 | |
| NORTHERN TRUST CORP |
13F
|
Company |
0.3%
|
101,332
|
$1,058,000 | — | 30 Jun 2018 | |
| Granahan Investment Management, LLC |
13F
|
Company |
0.17%
|
57,002
|
$595,000 | — | 30 Jun 2018 | |
| UNITED SERVICES AUTOMOBILE ASSOCIATION |
13F
|
Company |
0.16%
|
55,348
|
$578,000 | — | 30 Jun 2018 | |
| VANGUARD GROUP INC |
13F
|
Company |
0.12%
|
40,620
|
$424,000 | — | 30 Jun 2018 | |
| JPMORGAN CHASE & CO |
13F
|
Company |
0.11%
|
38,136
|
$398,000 | — | 30 Jun 2018 | |
| DEUTSCHE BANK AG\ |
13F
|
Company |
0.09%
|
29,716
|
$310,000 | — | 30 Jun 2018 | |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
|
Company |
0.09%
|
29,249
|
$305,000 | — | 30 Jun 2018 | |
| MORGAN STANLEY |
13F
|
Company |
0.08%
|
26,305
|
$275,000 | — | 30 Jun 2018 | |
| Cardinal Capital Management |
13F
|
Company |
0.08%
|
26,047
|
$272,000 | — | 30 Jun 2018 | |
| Bank of New York Mellon Corp |
13F
|
Company |
0.07%
|
22,789
|
$237,000 | — | 30 Jun 2018 | |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC |
13F
|
Company |
0.06%
|
21,100
|
$221,000 | — | 30 Jun 2018 | |
| TIAA CREF INVESTMENT MANAGEMENT LLC |
13F
|
Company |
0.05%
|
17,379
|
$181,000 | — | 30 Jun 2018 | |
| CALIFORNIA STATE TEACHERS RETIREMENT SYSTEM |
13F
|
Company |
0.05%
|
17,340
|
$181,000 | — | 30 Jun 2018 | |
| GOLDMAN SACHS GROUP INC |
13F
|
Company |
0.05%
|
16,990
|
$177,000 | — | 30 Jun 2018 | |
| AQR CAPITAL MANAGEMENT LLC |
13F
|
Company |
0.05%
|
16,131
|
$168,000 | — | 30 Jun 2018 | |
| TEACHERS ADVISORS, LLC |
13F
|
Company |
0.04%
|
15,254
|
$159,000 | — | 30 Jun 2018 | |
| Wealthspire Advisors, L.P. |
13F
|
Company |
0.04%
|
14,500
|
$151,000 | — | 30 Jun 2018 | |
| NEW YORK STATE COMMON RETIREMENT FUND |
13F
|
Company |
0.04%
|
12,400
|
$129,000 | — | 30 Jun 2018 | |
| Hartford Financial Management Inc. |
13F
|
Company |
0.03%
|
11,000
|
$115,000 | — | 30 Jun 2018 | |
| Creative Planning |
13F
|
Company |
0.03%
|
10,037
|
$105,000 | — | 30 Jun 2018 | |
| AMERICAN INTERNATIONAL GROUP, INC. |
13F
|
Company |
0.02%
|
7,381
|
$77,000 | — | 30 Jun 2018 | |
| UBS Group AG |
13F
|
Company |
0.01%
|
4,293
|
$45,000 | — | 30 Jun 2018 | |
| STRS OHIO |
13F
|
Company |
0.01%
|
3,300
|
$34,000 | — | 30 Jun 2018 | |
| Legal & General Group Plc |
13F
|
Company |
0%
|
1,681
|
$18,000 | — | 30 Jun 2018 | |
| CITIGROUP INC |
13F
|
Company |
0%
|
1,628
|
$17,000 | — | 30 Jun 2018 | |
| BANK OF AMERICA CORP /DE/ |
13F
|
Company |
0%
|
1,516
|
$16,000 | — | 30 Jun 2018 | |
| WELLS FARGO & COMPANY/MN |
13F
|
Company |
0%
|
1,388
|
$14,000 | — | 30 Jun 2018 | |
| Ameritas Investment Partners, Inc. |
13F
|
Company |
0%
|
914
|
$10,000 | — | 30 Jun 2018 | |
| BARCLAYS PLC |
13F
|
Company |
0%
|
830
|
$8,000 | — | 30 Jun 2018 | |
| Edge Wealth Management LLC |
13F
|
Company |
0%
|
502
|
$5,000 | — | 30 Jun 2018 | |
| BNP PARIBAS FINANCIAL MARKETS |
13F
|
Company |
0%
|
370
|
$3,863 | — | 30 Jun 2018 | |
| PIEDMONT INVESTMENT ADVISORS INC |
13F
|
Company |
0%
|
197
|
$2,000 | — | 30 Jun 2018 | |
| BANK OF MONTREAL /CAN/ |
13F
|
Company |
0%
|
81
|
$1,000 | — | 30 Jun 2018 | |
| ROYAL BANK OF CANADA |
13F
|
Company |
0%
|
69
|
$1,000 | — | 30 Jun 2018 | |
| Federation Des Caisses Desjardins du Quebec |
13F
|
Individual |
0%
|
1
|
$10 | — | 30 Jun 2018 |
Institutional Holders of FENNEC PHARMACEUTICALS INC. - Common stock, no par value (the "Shares") (FENC) as of Q3 2018
As of 30 Sep 2018,
FENNEC PHARMACEUTICALS INC. - Common stock, no par value (the "Shares") (FENC) was held by
45 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
9,435,050 shares.
The largest 10 holders included
Southpoint Capital Advisors LP, venBio Select Advisor LLC, Opaleye Management Inc., 683 Capital Management, LLC, EVENTIDE ASSET MANAGEMENT, LLC, BlackRock Inc., PUTNAM INVESTMENTS LLC, GRANAHAN INVESTMENT MANAGEMENT INC/MA, STATE STREET CORP, and NORTHERN TRUST CORP.
This page lists
45
institutional shareholders reporting positions in this security
for the Q3 2018 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q3 2018 vs Q2 2018 Across Filers
Q2 2018 holders
43
Q3 2018 holders
45
Holder diff
2
| Investor | Q2 2018 Shares | Q3 2018 Shares | Share Diff | Share Chg % | Q2 2018 Value $ | Q3 2018 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.